Skip to content

Prospective Community Cohort Study of Chronic Stable Angina Pectoris Treated with Suxiao Jiuxin Wan

Prospective Community Cohort Study of Chronic Stable Angina Pectoris Treated with Suxiao Jiuxin Wan

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OPC-17011644
Enrollment
Unknown
Registered
2017-06-13
Start date
2017-06-19
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Stable Angina Pectoris

Interventions

Suxiao Jiuxin Wan cohort:Choose patients who have used Suxiao Jiuxin Wan in the most recent month or will soon use this drug according to doctor's advice and patient needs to treat chronic stable angi
Compound Danshen Dripping Pill cohort:Choose patients who have used Compound Danshen Dripping Pill in the most recent month or will soon use this drug according to doctor's advice and patient needs to
Shexiang Baoxin Wan cohort:Choose patients who have used Shexiang Baoxin Wan in the most recent month or will soon use this drug according to doctor's advice and patient needs to treat chronic stable

Sponsors

Dongfang Hospital Affiliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diagnosed by the secondary or above hospital as chronic stable angina pectoris; 2. Age=18 years; 3. Good mobility and no cognitive dysfunction; 4. Long-term community residence, and voluntary participation in coronary heart disease community management.

Exclusion criteria

Exclusion criteria: Non

Design outcomes

Primary

MeasureTime frame
Frequency (number of angina pectoris attacks);Angina pectoris VAS score;Angina pectoris remission time;Total effective rate of angina pectoris remission;Changes in severity of angina pectoris;Nitroglycerin reduction or stop rate;Changes in Seattle Angina Questionnaire (SAQ);

Secondary

MeasureTime frame
Incidence of cardiovascular events;

Countries

China

Contacts

Public ContactLin Qian

Dongfang Hospital Affiliated to Beijing University of Chinese Medicine

13910565673@126.com+86 13910565673

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026